Update. Obes Rev 2010, 11:43045. 11. Rector RS, Thyfault JP, Wei Y, Ibdah JA

Update. Obes Rev 2010, 11:43045. 11. Rector RS, Thyfault JP, Wei Y, Ibdah JA: Non-alcoholic fatty liver illness and also the metabolic syndrome: an update. World J Gastroenterol 2008, 14:18592. 12. Tessari P, Coracina A, Cosma A, Tiengo A: Hepatic lipid metabolism and non-alcoholic fatty liver disease. Nutr Metab Cardiovasc Dis 2009, 19:29102. 13. Nagle CA, Klett EL, Coleman RA: Hepatic triacylglycerol accumulation and insulin resistance. J Lipid Res 2009, 50(Suppl):S749. 14. Pasumarthy L, Srour J: Nonalcoholic steatohepatitis: a review on the literature and updates in management. South Med J 2010, 103:54750. 15. Ruhl CE, Everhart JE: Epidemiology of nonalcoholic fatty liver. Clin Liver Dis 2004, eight:50119. vii. 16. Stefanovic-Racic M, Perdomo G, Mantell BS, Sipula IJ, Brown NF, O’Doherty RM: A moderate increase in carnitine palmitoyltransferase 1a activity is enough to substantially reduce hepatic triglyceride levels. Am J Physiol Endocrinol Metab 2008, 294:E96977. 17. Rector RS, Thyfault JP, Uptergrove GM, Morris EM, Naples SP, Borengasser SJ, Mikus CR, Laye MJ, Laughlin MH, Booth FW, Ibdah JA: Mitochondrial dysfunction precedes insulin resistance and hepatic steatosis and18.19.20. 21. 22.23. 24. 25.26.27.28.29.30.31.32. 33.34.35.36.37.38.39.contributes for the natural history of non-alcoholic fatty liver illness in an obese rodent model. J Hepatol 2010, 52:72736. Strauss RS, Barlow SE, Dietz WH: Prevalence of abnormal serum aminotransferase values in overweight and obese adolescents. J Pediatr 2000, 136:72733. Marchesini G, Bugianesi E, Forlani G, Cerrelli F, Lenzi M, Manini R, Natale S, Vanni E, Villanova N, Melchionda N, Rizzetto M: Nonalcoholic fatty liver, steatohepatitis, and also the metabolic syndrome. Hepatology 2003, 37:91723. Paschos P, Paletas K: Non alcoholic fatty liver disease and metabolic syndrome. Hippokratia 2009, 13:99. Choudhury J, Sanyal AJ: Insulin resistance as well as the pathogenesis of nonalcoholic fatty liver illness. Clin Liver Dis 2004, 8:57594. ix. Cao J, Li JL, Li D, Tobin JF, Gimeno RE: Molecular identification of microsomal acyl-CoA:glycerol-3-phosphate acyltransferase, a key enzyme in de novo triacylglycerol synthesis.Pseudouridine Proc Natl Acad Sci USA 2006, 103:196959700.Isosorbide dinitrate Coleman RA, Lee DP: Enzymes of triacylglycerol synthesis and their regulation. Prog Lipid Res 2004, 43:13476. Nimmo HG: Proof for the existence of isoenzymes of glycerol phosphate acyltransferase. Biochem J 1979, 177:28388. Haldar D, Tso WW, Pullman ME: The acylation of sn-glycerol 3-phosphate in mammalian organs and Ehrlich ascites tumor cells. J Biol Chem 1979, 254:4502509. Lewin TM, Granger DA, Kim JH, Coleman RA: Regulation of mitochondrial sn-glycerol-3-phosphate acyltransferase activity: response to feeding status is special in a variety of rat tissues and is discordant with protein expression.PMID:24733396 Arch Biochem Biophys 2001, 396:11927. Winder WW, Hardie DG: Inactivation of acetyl-CoA carboxylase and activation of AMP-activated protein kinase in muscle throughout workout. Am J Physiol 1996, 270:29904. McGarry JD, Mannaerts GP, Foster DW: A feasible part for malonyl-CoA in the regulation of hepatic fatty acid oxidation and ketogenesis. J Clin Invest 1977, 60:26570. Yeh YY, Zee P: Fatty acid oxidation in isolated rat liver mitochondria. Developmental alterations and their relation to Hepatic levels of Carnitine and glycogen and to Carnitine acyltransferase activity. Arch Biochem Biophys 1979, 197:56069. Tomita K, Tamiya G, Ando S, Kitamura N, Koizumi H, Kato S, Horie Y.